Long-term Reoperations After Lumbar Spinal Stenosis Surgery

NCT ID: NCT06407063

Last Updated: 2024-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

794 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-09-19

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Severe and persisting pain and disability due to a degenerative narrowing of the spinal canal, lumbar spinal stenosis, can be operated with a simple surgical decompression. Sometimes, there is also a slippage of vertebra, degenerative spondylolisthesis. In such cases, instrumental stabilization (e.g. screws and rods) has been recommended. Even though additional fusion is more complex and riskier, and evidence in high-quality Scandinavian studies shows that it is unnecessary, decompression plus fusion is still the treatment of choice in the USA and most European countries. This reluctance to change clinical practice is mainly due to concerns about long-term results, especially higher reoperation rates among patients operated with decompression only. This register-based non-inferiority study aims to assess long-term reoperations among those treated with and without additional fusion surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The use of fusion surgery in addition to decompression in the treatment of degenerative lumbar spondylolisthesis (DS) with spinal stenosis (LSS) is a long-standing controversy in spine surgery. The main goal of LSS surgery is to decompress the nerve roots. In the 1990s, two observational studies recommended that decompression with additional fusion should be the treatment of choice. Consequently, the practice shifted towards more complex fusion procedures. In 2016, Swedish and one American randomized controlled trials (RCTs), one Swedish and one American, reported conflicting data about reoperations. The study from the US showed a higher frequency of reoperations after decompression only compared to the decompression and fusion, while the Swedish study showed no difference. In 2020, Austevoll et. al. published a study from the Norwegian registry for spine surgery (NORspine) comparing relative effectiveness micro-decompression alone vs decompression and instrumented fusion (5). This study had a non-inferiority design, similar to the RCT published by the same author in 2021 (6). Both studies concluded that micro-decompression alone was non-inferior to decompression and instrumented fusion regarding clinical outcomes and reoperation rates. Despite an increasing number of studies showing no extra benefits from the more risky and complex additional fusion procedures, the surgical practice has changed little outside Scandinavia. This is probably due to the concerns about subsequent instability and higher long-term reoperation rates among those operated with decompression only.

This study is a long-term follow-up of the NORspine relative effectiveness study from 2020, comprising 794 patients having an index operation for LSS and DS between September 19th 2007 and December 21st 2015 (index study). The present study aims to assess long-term reoperations resulting from everyday clinical practice. The investigators alternative hypothesis is that micro-decompression alone is non-inferior to decompression plus instrumented fusion. The non-inferior margin is specified to correspond to a number needed to treat = 8 to avoid reoperation on one patient in the first 10 postoperative years, corresponding to a between-group difference of 12.5 percentage points (100/8 = 12.5).

The dataset will contain NORspine data at baseline, 3 months, one year and long-term follow-up performed at 7 to 15 years (NCT03469791). NORspine also provides dates of death for all deceased patients. The Norwegian Patient Registry (NPR) will serve as an external data source, providing data about all reoperations until August 31st 2023 and the baseline Charlson Comorbidity Index (CCI). NPR data will ensure follow-up of 8 to 16 years concerning reoperations. For these cases, a review the electronic health records to validate NPR data regarding classification of reoperation (level, indication, surgical technique, total number of reoperations, spinal cord stimulation, reoperations within 90 days after the index operation, participation in other studies).

In the index study propensity score matching (PSM) was performed to reduce the risk of selection bias due to case-mix. The same PSM will be used in the present study. matching. The following parameters were included in the calculation of the propensity score: Age; Gender; American Society of Anaesthesiologists (ASA) grade; Body Mass Index (BMI); Smoking, Oswestry Disability Index (ODI), Numeric Rating Scale for leg pain and back pain, Euroqol 5D (EQ-5D-3L), foraminal stenosis, degenerative disc disease, predominating back pain, number of levels operated on and neurological palsy. The propensity scores were derived from a logistic regression model and reflected a patient's theoretical baseline probability for being instrumentally fused. Using the '1:1 matching without replacement' method, pairs of fused and non-fused patients with a difference in propensity scores less than 0.2 in the logit of the standard deviation were formed. Statistical Package for the Social Sciences (SPSS) version 24 was used for propensity score matching. For comparison, complete case analyses will also be performed.

In this non-inferiority designed study, the primary outcome will be the occurrence of a reoperation, defined as new lumbar spine operation more than 90 days after the index operation until August 31st 2023 (range: from 8 to 16 years after the primary operation. The rate of reoperation within 90 days (n%) of will be reported separately, and will be classified as a complication to the index operation. Survival analysis will be used to detect whether the probability for reoperation during the first 10 years is more than 12.5 % higher (non-inferiority margin) in the micro-decompression group than in the decompression and instrumented fusion group or not. This is to be tested by deriving a 90 % confidence interval (CI) for the difference of the survival function (S(t)) at 10 years between the groups (S(t) in decompression and instrumented fusion group - S(t) in micro-decompression group) where t = 10 years. Thus, a lower limit of the CI above -0.125 will indicate that, in an everyday clinical practice setting, micro-decompression would be non-inferior to decompression and instrumented fusion regarding the risk of reoperation. In addition, the investigators will report survival functions and observed reoperation rates at multiple timepoints (2, 5 and 10 years), hazard ratio (HR) for reoperation (at 2, 5 and 10 years, as well as complications (including reoperations within 90 days). The indication for reoperation, surgical techniques and risk factors associated with reoperation will also be investigated.

For the power analysis conducted with PASS 2019, two assumptions were made. 1) Expected reoperation rate: Based on NORspine data, about 27.1 % of lumbar surgical procedures are performed on patients previously operated. Using this as a proxy for the expected probability of reoperation in the total cohort. 2) HR = 1.6 (decompression and instrumented fusion) approximates the event ratio between the groups. Applying these assumptions, choosing a type 1 error = 0.05 and power 0.8 gives sample size = 269 per group. The index study had a sample size of 285 in each PSM group. Since the present study will use national administrative registries and patient's health records, substantial loss to follow-up is not expected.

For statistical analyses SAS Enterprise Guide 8.3 will be used, including descriptive statistics, tests for data distribution, cross-tabulations with χ2 test, Student t-tests, and Mann-Whitney U tests. Reoperation survival, hazard and rates will be assessed by stratified log-rank test, cox regression modelling (time-dependent if the proportional hazard assumption is violated), Kaplan-Meier plots and multivariable regression analyses.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Degenerative Lumbar Spondylolisthesis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Degenerative Spondylolisthesis Treatment Decompression alone Instrumented fusion Reoperations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients treated for Degenerative Spondylolisthesis

Patients operated for Degenerative Spondylolisthesis with Lumbar Spinal Stenosis

Micro-decompression alone

Intervention Type PROCEDURE

In surgical treatment of Degenerative Spondylolisthesis patients are operated on with a midline-preserving decompression without fusion

Decompression and instrumented fusion

Intervention Type PROCEDURE

In surgical treatment of Degenerative Spondylolisthesis patients are operated on with a decompression followed by an instrumental fusion with or without an additional cage

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Micro-decompression alone

In surgical treatment of Degenerative Spondylolisthesis patients are operated on with a midline-preserving decompression without fusion

Intervention Type PROCEDURE

Decompression and instrumented fusion

In surgical treatment of Degenerative Spondylolisthesis patients are operated on with a decompression followed by an instrumental fusion with or without an additional cage

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* operated between September 2007 and December 2015 labeled in the registry with both 'Spinal stenosis' and 'Degenerative spondylolisthesis'
* operated on with decompression with or without an additional fusion

Exclusion Criteria

* operated with an anterior approach
* had a former operation at index Level
* was labeled with a degenerative scoliosis
* was operated in more than 2 Levels
* was operated with non-instrumented fusion
* operated with a standard laminectomy with removing of the posterior midline structures or operated without magnifying devices was excluded from the micro-decompression group
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Royal Norwegian Ministry of Health

OTHER

Sponsor Role collaborator

Haukeland University Hospital

OTHER

Sponsor Role collaborator

University Hospital of North Norway

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tore Solberg, Prof

Role: PRINCIPAL_INVESTIGATOR

University Hospital of North Norway

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University hospital of North Norway

Tromsø, , Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eirik Mikkelsen, MD

Role: CONTACT

Email: [email protected]

Tore Solberg, Prof

Role: CONTACT

Phone: +47 91364531

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tore Solberg, Prof

Role: primary

Erik Mikkelsen, MD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Herkowitz HN, Kurz LT. Degenerative lumbar spondylolisthesis with spinal stenosis. A prospective study comparing decompression with decompression and intertransverse process arthrodesis. J Bone Joint Surg Am. 1991 Jul;73(6):802-8.

Reference Type BACKGROUND
PMID: 2071615 (View on PubMed)

Bridwell KH, Sedgewick TA, O'Brien MF, Lenke LG, Baldus C. The role of fusion and instrumentation in the treatment of degenerative spondylolisthesis with spinal stenosis. J Spinal Disord. 1993 Dec;6(6):461-72. doi: 10.1097/00002517-199306060-00001.

Reference Type BACKGROUND
PMID: 8130395 (View on PubMed)

Forsth P, Olafsson G, Carlsson T, Frost A, Borgstrom F, Fritzell P, Ohagen P, Michaelsson K, Sanden B. A Randomized, Controlled Trial of Fusion Surgery for Lumbar Spinal Stenosis. N Engl J Med. 2016 Apr 14;374(15):1413-23. doi: 10.1056/NEJMoa1513721.

Reference Type BACKGROUND
PMID: 27074066 (View on PubMed)

Ghogawala Z, Dziura J, Butler WE, Dai F, Terrin N, Magge SN, Coumans JV, Harrington JF, Amin-Hanjani S, Schwartz JS, Sonntag VK, Barker FG 2nd, Benzel EC. Laminectomy plus Fusion versus Laminectomy Alone for Lumbar Spondylolisthesis. N Engl J Med. 2016 Apr 14;374(15):1424-34. doi: 10.1056/NEJMoa1508788.

Reference Type BACKGROUND
PMID: 27074067 (View on PubMed)

Austevoll IM, Gjestad R, Solberg T, Storheim K, Brox JI, Hermansen E, Rekeland F, Indrekvam K, Hellum C. Comparative Effectiveness of Microdecompression Alone vs Decompression Plus Instrumented Fusion in Lumbar Degenerative Spondylolisthesis. JAMA Netw Open. 2020 Sep 1;3(9):e2015015. doi: 10.1001/jamanetworkopen.2020.15015.

Reference Type BACKGROUND
PMID: 32910195 (View on PubMed)

Austevoll IM, Hermansen E, Fagerland MW, Storheim K, Brox JI, Solberg T, Rekeland F, Franssen E, Weber C, Brisby H, Grundnes O, Algaard KRH, Boker T, Banitalebi H, Indrekvam K, Hellum C; NORDSTEN-DS Investigators. Decompression with or without Fusion in Degenerative Lumbar Spondylolisthesis. N Engl J Med. 2021 Aug 5;385(6):526-538. doi: 10.1056/NEJMoa2100990.

Reference Type BACKGROUND
PMID: 34347953 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2813

Identifier Type: -

Identifier Source: org_study_id